Sfoglia per RIVISTA
CANCER IMMUNOLOGY, IMMUNOTHERAPY : CII
Collezione AO Ordine Mauriziano

  

Items : 3

Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2024 Nov 2;74(1):6. doi: 10.1007/s00262-024-03860-w.

2024
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Sangiolo D; Primo L; Puliafito A; Valabrega G; Vigna E; Merlini A; Tuninetti V; D'Ambrosio L; Lombardi AM; Vitali L; Proment A; Capellero S; Rotolo R; Donini C; Massa A; Leuci V; Galvagno F;

Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2024 Jul 2;73(9):161. doi: 10.1007/s00262-024-03741-2.

2024
ASL Cuneo 2
AO Ordine Mauriziano

Rescigno P; Fornarini G; Buti S; Rebuzzi SE; Vignani F; Cavo A; Signori A; Banna GL; Tudini M; Malgeri A; Nole F; Prati G; Morelli F; Messina M; Di Napoli M; Atzori F; Prati V; Soraru M; Panni S; Mollica V; Pipitone S; Ricotta R; Fratino L; Catalano F; Milella M; Procopio G; Naglieri E; Masini C; Zucal PA; et alii...

Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2022 Apr;71(4):865-874. doi: 10.1007/s00262-021-03045-9. Epub 2021 Aug 31

2022
AO Ordine Mauriziano

Brocco D; Porzio G; Piras M; Rijavec E; Simionato F; Natoli C; Santini D; Vincenzi B; Tonini G; Tiseo M; Marconcini R; Audisio M; Intagliata S; Lai E; Aprile G; Buti S; Ghidini M; Inno A; Macrini S; Di Marino P; Nicolardi L; Tuzi A; Occhipinti MA; Pergolesi F; Veltri E; Filetti M; Adamo V; Ficorella C; Citarella F; et alii...